Predicting drug response and toxicity based on gene polymorphisms
- 30 June 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 54 (3) , 171-196
- https://doi.org/10.1016/j.critrevonc.2005.01.005
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tractInternational Journal of Cancer, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Single nucleotide polymorphisms in the XPG gene: Determination of role in DNA repair and breast cancer riskInternational Journal of Cancer, 2002
- Identification of four single nucleotide polymorphisms in DNA repair genes:XPA andXPB(ERCC3) in Polish populationHuman Mutation, 2000
- Glucuronidation of 7-Ethyl-10-hydroxycamptothecin (SN-38) by the Human UDP-Glucuronosyltransferases Encoded at the UGT1 LocusBiochemical and Biophysical Research Communications, 1999
- Interindividual Differences in Hepatic Expression of CYP3A4: Relationship to Genetic Polymorphism in the 5′-Upstream Regulatory RegionBiochemical and Biophysical Research Communications, 1999
- Annotation Molecular genetics of methylenetetrahydrofolate reductase deficiencyJournal of Inherited Metabolic Disease, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- DNA damage, oncogenesis and the p53 tumour-suppressor geneMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994